Assay Detail
Binding
CHEMBL2446028
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of Hepatitis C virus genotype 1b NS3/4A protease D168V mutant
8
Total Activities
4
Compounds Tested
2
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Hepatitis C virus subtype 1b |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| EC90 | 4 | - | - |
| EC50 | 4 | 6.72 | 7.10 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL231813 | TELAPREVIR | 4.0 | 2 | 7.10 |
| CHEMBL218394 | BOCEPREVIR | 4.0 | 2 | 6.66 |
| CHEMBL2441773 | — | — | 2 | 6.40 |
| CHEMBL4525964 | VANIPREVIR | 3.0 | 2 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL231813 | TELAPREVIR | EC50 | = | 80.0 | nM | 7.10 |
| CHEMBL218394 | BOCEPREVIR | EC50 | = | 220.0 | nM | 6.66 |
| CHEMBL2441773 | — | EC50 | = | 400.0 | nM | 6.40 |
| CHEMBL4525964 | VANIPREVIR | EC90 | > | 1.0 | uM | - |
| CHEMBL2441773 | — | EC90 | = | 3.3 | uM | - |
| CHEMBL231813 | TELAPREVIR | EC90 | = | 0.74 | uM | - |
| CHEMBL218394 | BOCEPREVIR | EC90 | = | 0.9 | uM | - |
| CHEMBL4525964 | VANIPREVIR | EC50 | > | 1000.0 | nM | - |